Why HR Leaders Should Care About 340B

As the second-largest federal drug program in the U.S., the 340B program plays a vital role in helping hospitals and clinics stretch limited resources and serve vulnerable communities. But as new challenges emerge – from growing regulatory pressure to the spread of misinformation – the future of 340B remains uncertain.

In this episode of The ASHHRA Podcast, RxBenefits Strategic Hospital Advisor Sarah Hearn and 340B advocate Rhiannon Klein join co-host Bo Brabo for a discussion on where things stand and what HR leaders need to know.

This episode covers:

What 340B is, why it exists, and how it supports care delivery in vulnerable communities
Why HR and pharmacy must collaborate to protect 340B savings and how doing so can help dramatically reduce employee drug costs
Getting clarity on the challenges unfolding behind the scenes
How advocates are pushing back on industry misinformation and why HR leaders need to be part of that conversation
Strategies for reinvesting 340B savings into employee health and community support

Why This Matters for HR

The 340B program is an important resource for long-term sustainability, and HR is uniquely positioned to help protect and optimize it. Understanding 340B is essential to making informed, proactive decisions that benefit employees, the organization, and the broader community. With the right insights and the right partners, HR can drive smarter healthcare spending and help protect the future of hospital-based care.

Backed by Apexus-certified expertise, RxBenefits partners with hospitals and health systems to offer extensive expertise on navigating the 340B program and strategically leveraging the full extent of its benefits through PBM-hospital relationships.

Listen now to gain clarity on how to navigate 340B with confidence.

Listen Now!